Differential expression of nonmuscle myosin II isoforms in human atherosclerotic plaque

Atherosclerosis

Volumn 130, Issue 1-2, 1997, Pages 71-85

  Nikol, Sigrid ^a,b   Murakami, Noriko ^c   Pickering, J Geoffrey ^a   Kearney, Marianne ^a   Leclerc, Guy ^a   Höfling, Berthold ^b   Isner, Jeffrey M ^a   Weir, Lawrence ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

atherect omy; atherosclerosis; differentiation; nonmuscle myosin; proliferation; restenosis; smooth muscle cell

Indexed keywords

MYOSIN;

ARTICLE; ATHERECTOMY; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; DIFFERENTIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

AGED; ANTIBODY SPECIFICITY; ARTERIES; ARTERIOSCLEROSIS; ATHERECTOMY; BLOTTING, WESTERN; CELLS, CULTURED; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MUSCLE, SMOOTH, VASCULAR; MYOSIN HEAVY CHAINS; MYOSIN SUBFRAGMENTS; RECURRENCE;

EID: 0030968643     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)06047-9     Document Type: Article

References (68)

1. Ross P. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
2. Fuster V, Badimon L, Badimon JJ, Cheesbro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-250.
3. Schwartz SM, Campbell GR, Campbell JH. Replication of smooth muscle cells in vascular disease. Circ Res 1986;58:427-444.
4. Campbell GR, Campbell JH. Smooth muscle phenotypic changes in arterial wall hemostasis: implications for the pathogenesis of atherosclerosis. Exp Mol Pathol 1985;42:139-162.
5. Campbell GR, Campbell JH, Manderson JA, Horrigan S, Rennick RE. Arterial smooth muscle. Arch Pathol Lab Med 1988;112:977-986.
6. Kocher O, Skalli O, Bloom WS, Gabbiani G. Cytoskeleton of rat aortic smooth muscle cells. Normal conditions and experimental intimal thickening. Lab Invest 1984;50:645-652.
7. Kocher O, Skalli O, Cerutti D, Gabbiani F, Gabbiani G. Cytoskeletal features of rat aortic cells during development. An electron microscopic immunohistochemical, and biochemical study. Circ Res 1985;56:829-838.
8. Ueda M, Becker T, Tsukada T, Numano F, Fujimoto T. Fibrocellular tissue response after percutaneous transluminal coronary angioplasty. Circulation 1991;83:1327-1332.
9. Isner JM. Frequency in nonangioplasty patients of morphologic findings reported in coronary arteries treated with transluminal angioplasty. Am J Cardiol 1983;51:689-693.
10. Kragel AH, Reddy SG, Wittes JT, Roberts WC. Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death. Circulation 1989;80:1747-1756.
11. Johnson DE, Hinohara JT, Selmon MR, Braden LJ, Simpson JB. Primary peripheral arterial stenoses and restenoses excised by transluminal atherectomy: a histopathologic study. J Am Coll Cardiol 1990;15:419-425.
12. Austin GE, Ratliff NB, Hillman J, Tabei S, Phillips DF. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985;6:369-375.
13. Nobuyoshi M, Kimura T, Ohishi H, Horivch H, Nosaka H, Hamasaki N, Yokoi H, Kim K. Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. J Am Coll Cardiol 1985;17:433-439.
14. Garrett KN, Edwards WD, Kaufman VP, Viestra RE, Holmes DR. Differential histopathology of primary atherosclerotic and restenotic lesions in coronary arteries and saphenous vein bypass grafts: analysis of tissue obtained from 73 patients by directional atherectomy. J Am Coll Cardiol 1991;17:442-448.
15. Pickering JG, Weir L, Jekanowski J, Kearney M, Isner JM. Proliferative activity in atherosclerotic plaque among patients undergoing percutaneous revascularization. J Clin Invest 1993;91:1469-1480.
16. O'Brien ER, Alpers CE, Stewart DK, Ferguson M, Tran N, Gordon D, Benditt EP, Hinohara JT, Simpson JB, Schwartz SM. Proliferation in primary and restenotic coronary atherectomy tissues. Circ Res 1993;73:223-231.
17. Warrick HM, Spudich JA. Myosin structure and function in cell motility. Annu Rev Cell Biol 1987;3:379-421.
18. Xu J-Q, Harder BA, Uman P, Craig R. Myosin filament structure in vertebrate smooth muscle. J Cell Biol 1996;134:53-66.
19. Cooke PH, Fay FS, Craig R. Myosin filaments isolated from skinned amphibian smooth muscle cells are side-polar. J Muscle Res Cell Motil 1989;10:206-220.
20. Nagai R, Kuro-o M, Babij P, Periasamy M. Identification of two types of smooth muscle myosin heavy chain isoforms by cDNA cloning and immunoblot analysis. J Biol Chem 1989;264:9734-9737.
21. Babij P, Periasamy M. Myosin heavy chain isoform diversity in smooth muscle is produced by differential RNA processing. J Mol Biol 1989;210:673-679.
22. Matsuoka R, Yoshida MC, Furutani Y, Imamura S, Kanda N, Yanagisawa T, Masaki T, Takao A. Human smooth muscle heavy chain gene mapped to chromosomal region 16q12. Am J Med Genet 1993;46:61-67.
23. Simons M, Wang M, McBride OW, Kawamoto S, Gdula D, Adelstein RS, Weir L. Human nonmuscle myosin heavy chains are encoded by two genes located on different chromosomes. Circ Res 1991;69:530-539.
24. Saez CG, Myers DC, Shows TB, Leinwand LA. Human nonmuscle myosin heavy chain mRNA: generation of diversity through alternative polyadenylation. Proc Natl Acad Sci USA 1990;87:1164-1168.
25. Toothaker LE, Gonzalez DA, Tung N, Lemons RS, LeBeau MM, Arnout MA, Clayton LK, Tenen DG. Cellular myosin heavy chain in human leukocytes: isolation of 5′ cDNA clones, characterization of the protein, chromosomal localization, and upregulation during myeloid differentiation. Blood 1991;78:1826-1833.
26. Takahashi M, Kawamoto S, Adelstein RS. Evidence for inserted sequences in the head region of nonmuscle myosin specific to the nervous system. J Biol Chem 1992;267:17864-17871.
27. Spudich JA. In pursuit of myosin function. Cell Regul 1989;1:1-11.
28. De Lozanne A, Spudich JA. Disruption of the Dictyostelium myosin heavy chain gene by homologous recombination. Science 1987;236:1081-1091.
29. Knecht DA, Loomis WF. Antisense RNA inactivation of myosin heavy chain gene expression in Dictyostelium discoideum. Science 1987;236:1081-1086.
30. Simons M, Rosenberg RD. Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro. Circ Res 1992;70:835-843.
31. Katsuragawa Y, Yanagisawa Y, Inoue A, Masaki T. Two distinct nonmuscle myo sin-heavy-chain mRNAs are differentially expressed in various chicken tissues. Eur J Biocem 1989;184:611-616.
32. Murakami N, Trenkner E, Elzinga M Changes in expression of nonmuscle myosin heavy chain isoforms during muscle and nonmuscle tissue development. Dev Biol 1993;157:19-27.
33. Borrione AC, Zanatello AMC, Scannapieco G, Pauletto P, Sartore S. Myosin heavy chain isoforms in adult and developing rabbit vascular smooth muscle. Eur J Biochem 1989;183:413-417.
34. Kuro-o M, Nagai R, Nakahara K-I, Katoh H, Tsai R-C, Tsuchimochi H, Yazaki Y, Ohkubo A, Takaku F. cDNA cloning of a myosin heavy chain isoform in embryonic smooth muscle and its expression during vascular development and in arteriosclerosis. J Biol Chem 1991;266:3768-3773.
35. Kawamoto S, Adelstein RS. Characterization of myosin heavy chains in cultured aorta smooth muscle cells. J Biol Chem 1987;262:7282-7288.
36. Zanellato AMC, Borrione AC, Tonello M, Scannapieco G, Pauletto P, Sartore S. Myosin isoform expression and smooth muscle cell heterogeneity in normal and atherosclerotic rabbit aorta. Arteriosclerosis 1990;10:996-1009.
37. Kuro-o M, Nagai R, Tsuchimochi H, Katoh H, Yazaki Y, Ohkubo A, Takaku F. Developmentally regulated expression of vascular smooth muscle myosin heavy chain isoforms. J Biol Chem 1989;264:18292-18295.
38. Gordon D, Schwartz SM. Arterial smooth muscle differentiation. In: Vascular smooth muscle in culture. Boca Raton: CRC Press, 1987:1-14.
39. Grunwald J, Fingerle J, Hammerle H, Betz E, Haudenschild CC. Cytocontractile structures and proteins of smooth muscle cells during the formation of experimental lesions. Exp Mol Pathol 1987;46:78-88.
40. Eddinger TD, Murphy RA. Developmental changes in actin and myosin heavy chain isoform expression in smooth muscle. Arch Biochem Biophys 1991;284:232-237.
41. Thyberg J, Hedin U, Sjolund M, Palmberg L, Bottger BA. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis 1990;10:966-990.
42. Palmberg L, Sjolund M, Thyberg J. Phenotypic modulation in primary cultures of arterial smooth muscle cells: reorganization of the cytoskeleton and activation of synthetic activities. Differentiation 1985;29:275-283.
43. Thyberg J, Nilsson J, Palmberg L, Sjolund M. Adult smooth muscle cells in primary culture. Modulation from contractile to synthetic phenotype. Cell and Tissue Res 1985;239:69-74.
44. Owens GK, Loeb A, Gordon D, Thompson MM. Expression of smooth muscle specific α-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J Cell Biol 1986;102:343-352.
45. Campbell JH, Kocher O, Skalli O, Gabbiani G, Campbell GR. Cytodifferentiation and expression of alpha-smooth muscle cell actin mRNA and protein during primary culture of aortic smooth muscle cells. Correlation with cell density and proliferative state. Arteriosclerosis 1989;9:633-643.
46. Bochaton-Poallat ML, Gabbiani F, Ropraz P, Gabbiani G. Cultured aortic smooth muscle cells from newborn and adult rats show distinct cytoskeletal features. Differentiation 1992;49:175-185.
47. Gabbiani G, Kocher O, Bloom WS, Vanderkerckhove J, Weber K. Actin expression of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media. J Clin Invest 1984;73:148-152.
48. Murakami N, Elzinga M. Immunohistochemical studies on the distribution of cellular myosin II isoforms in brain and aorta. Cell Motil Cytoskelet 1992;22:281-295.
49. Murakami N, Mehta P, Elzinga M. Studies on the distribution of cellular myosin with antibodies to isoform-specific synthetic peptides. FEBS Letts 1991;278:23-25.
50. Kawamoto S, Adelstein RS. Chicken nonmuscle myosin heavy chains: Differential expression of two mRNAs and evidence for two different polypeptides. J Cell Biol 1991;112:917-925.
51. Leclerc G, Isner JM, Kearney M, Simons M, Safian RD, Baim DS, Weir L. Evidence implicating nonmuscle myosin in restenosis. Circulation 1992;85:543-553.
52. Simons M, Leclerc G, Safian RD, Isner JM, Weir L, Baim DS. Relation between activated smooth muscle cells in coronary artery lesions and restenosis after angioplasty. N Engl J Med 1993;328:608-613.
53. Simpson JB, Selmon MR, Robertson GC, Cipriano PR, Hayden WG, Johnson DE, Fogarty TJ. Transluminal atherectomy for occlusive peripheral vascular disease. Am J Cardiol 1988;61:96G-101G (abstract).
54. Safian RD, Gelbfish JS, Erny RE, Schmitt SJ, Schmitt DA, Baim DS. Coronary atherectomy: clinical, angiographic, and histological findings and observations regarding potential mechanisms. Circulation 1990;82:69-79.
55. Kelley CA, Sellers JR, Goldsmith PK, Adelstein RS. Smooth muscle myosin is composed of homodimeric heavy chains. J Biol Chem 1992;267:2127-2130.
56. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
57. Laemmli UK. Cleavage of structural proteins during the assembly of the head of a bacteriophage. Nature 1970;227:680-685.
58. Harlow E, Lane D. Antibodies: a laboratory manual. New York: Cold Spring Harbor Laboratory Press, 1988.
59. Engvall E, Ruoslahti E. Binding of a soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer 1977;10:1-10.
60. Kleinman HK, McGarvey ML, Liotta LA, Robey PG, Tryggvason K, Martin GR. Isolation and characterization of type IV procollagen, laminin, and heparan sulphate proteoglycan from the EHS sarcoma. Biochemistry 1982;21:6188-6193.
61. Hoefler H, Childers H, Montminy RR, Lechan RM, Goodman RH, Wolfe HJ. In situ hybridization methods for the detection of somatostatin mRNA in tissue sections using antisense RNA probes. Histochen J 1986;18:597-604.
62. Brown LF, Yeo K-T, Berse B, Yeo T-K, Senger DR, Dvorak HF, Van De Water L. Expression of vascular permiability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992;176:1375-1379.
63. Nelken NA, Soifer SJ, O'Keefe J, Vu T-KH, Charo IF, Coughlin SR. Thrombin receptor expression in normal and atherosclerotic human arteries. J Clin Invest 1992;90:1614-1616.
64. Lawrence JB, Singer RH. Intracellular localization of messenger RNAs for cytoskeletal proteins. Cell 1986;45:407-415.
65. Grainger DJ, Hesketh TR, Metcalfe JC, Weissberg PL. A large accumulation of non-muscle myosin occurs at first entry into M phase in rat vascular smooth-muscle cells. Biochem J 1991;277:145-151.
66. Sun W, Chantler PD. Cloning of the cDNA encoding a neuronal myosin heavy chain from mammalian brain and its differential expression within the central nervous system. J Mol Biol 1992;224:1185-1193.
67. Aikawa M, Sivam PN, Kuro-o M, Kimura K, Nakahara K, Takewaki S, Ueda M, Yamaguchi H, Yazaki Y, Periasamy M, Nagai R. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ Res 1993;73:1000-1012.
68. Rovner AS, Murphy RA, Owens GK. Expression of smooth muscle and nonmuscle myosin heavy chains in cultured vascular smooth muscle cells. J Biol Chem 1986;261:14740-14745.